(EMAILWIRE.COM, October 18, 2019 ) The report "Medical Membranes Market by material (PTFE, PVDF, PP, PSU & PESU), Process Technology (UF, MF, NF), Application (Pharmaceutical Filtration, Hemodialysis, Drug Delivery, IV Infusion & Sterile Filtration), and Region-Global forecast to 2022" The medical membranes market is expected to reach USD 3.31 Billion by 2022. The medical membranes market is projected to grow from USD 2.13 Billion in 2017 to USD 3.31 Billion by 2022, at a CAGR of 9.2% during the forecast period. This growth can be attributed to the increase in the number of ESRD patients worldwide. Moreover, the demand for artificial organs and organ transplant will also propel the growth of the medical membranes market in the healthcare sector. The rising incidences of patients undergoing dialysis is another factor driving the demand for medical membranes.

Download PDF brochure of Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=86

The PSU & PESU material segment is estimated to lead the medical membranes market in 2017.

The increasing use of PSU & PESU in pharmaceutical filtration and hemodialysis is one of the most significant factors contributing to the growth of the PSU & PESU segment. These materials are widely used in medical applications, such as sample preparation, sterile filtration, pre-filtration, venting & gas filtration, and infusion therapy. They are used as waste-treatment membranes, owing to their excellent mechanical and thermal properties. PESU is an inherently hydrophilic membrane that provides fast filtration and superior flow rate and is used in aqueous solutions to remove fine particles, bacteria, and fungi. It is also used to manufacture MF, UF, and gas separation membranes, owing to its unique properties, such as outstanding thermal, mechanical, and hydrolytic strength, both in the hot and wet environment.

Nanofiltration is expected to be fastest-growing process technology during the forecast period.

Nanofiltration is a relatively new membrane filtration process used for the purpose of softening (polyvalent cation removal) and removal of disinfection byproducts. NF membranes reject multivalent ions with no selectivity towards monovalent ions, whereas RO membranes reject all solutes, including monovalent ions. This property enables NF membranes to operate at reduced operating pressures with increased flow rates as compared to RO. Thus, the use of nanofiltration process technology is gaining momentum in the market. In addition, research & development in solvent-stable membranes has expanded the applicability of nanofiltration in new areas, such as pharmaceuticals and fine chemicals, thereby driving the demand for nanofiltration process technology.

Don't miss out on business opportunities in Medical Membranes Market. Speak to Our Analyst and gain crucial industry insights that will help your business grow. https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=86

Browse in-depth TOC on "Medical Membranes Market”
65 - Market Data Tables
31 - Figures
129 - Pages

Pharmaceutical filtration is the largest application segment of the medical membranes market.

High incidences of renal disease, advancements in medical technology, expansion of the pharmaceutical and healthcare industries, and demand for high purity products and medicines are major factors driving the growth of the pharmaceutical application segment of the medical membranes market.

Europe led the medical membranes market in 2017.

The growth of the medical membranes market in Europe can be attributed to the increase in the number of ESRD patients, availability of improved diagnostic facilities, and high prevalence of chronic diseases, such as diabetes and hypertension.

Pall Corporation (US), Asahi Kasei (Japan), 3M (US), Koch Membrane Systems (US), Merck Millipore (US), and GE Healthcare (US) are major players operating in the medical membranes market.

Get this report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=86

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.